Kolon Life Science Inc
KOSDAQ:102940
Kolon Life Science Inc
Operating Expenses
Kolon Life Science Inc
Operating Expenses Peer Comparison
Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors
Company | Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
K
|
Kolon Life Science Inc
KOSDAQ:102940
|
Operating Expenses
-₩36.5B
|
CAGR 3-Years
7%
|
CAGR 5-Years
4%
|
CAGR 10-Years
-4%
|
Yuhan Corp
KRX:000100
|
Operating Expenses
-₩509.1B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-8%
|
|
SK Biopharmaceuticals Co Ltd
KRX:326030
|
Operating Expenses
-₩358.3B
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
N/A
|
|
Hanmi Pharm Co Ltd
KRX:128940
|
Operating Expenses
-₩608.6B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-6%
|
|
S
|
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
|
Operating Expenses
-₩87.4B
|
CAGR 3-Years
0%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-8%
|
C
|
Celltrion Pharm Inc
KOSDAQ:068760
|
Operating Expenses
-₩83.6B
|
CAGR 3-Years
-19%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
-12%
|
See Also
What is Kolon Life Science Inc's Operating Expenses?
Operating Expenses
-36.5B
KRW
Based on the financial report for Dec 31, 2023, Kolon Life Science Inc's Operating Expenses amounts to -36.5B KRW.
What is Kolon Life Science Inc's Operating Expenses growth rate?
Operating Expenses CAGR 10Y
-4%
Over the last year, the Operating Expenses growth was -6%. The average annual Operating Expenses growth rates for Kolon Life Science Inc have been 7% over the past three years , 4% over the past five years , and -4% over the past ten years .